Infinity Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview

Infinity Pharmaceuticals

02/06/2023 21:32

* Infinity Pharmaceuticals Inc  INFI.OQ   INFI.O  is
expected
to show a rise in quarterly revenue when it reports  results on
June 5 (estimated). 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 2.0% increase in revenue to $700 thousand from $686 thousand
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Infinity
Pharmaceuticals
Inc is for a loss of 12 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 4.5%
in the last three months. ​
    * Wall Street's median 12-month price target for Infinity
Pharmaceuticals Inc is $0.3​, above​ its last closing price
of $0.18. ​​​

This summary was machine generated June 2 at 20:32 GMT.  All
figures in US dollars  unless otherwise stated